The Indian Hume Pipe Company Limited (BOM:504741)

ASLAN Pharmaceuticals Revenue

The Indian Hume Pipe Company had revenue of 3.19B INR in the quarter ending June 30, 2025, a decrease of -12.31%. This brings the company's revenue in the last twelve months to 14.45B, up 2.79% year-over-year. In the fiscal year ending March 31, 2025, The Indian Hume Pipe Company had annual revenue of 14.91B with 7.39% growth.

• Revenue (ttm): 14.45B
• Revenue Growth: +2.79%
• P/S Ratio: 1.39
• Revenue / Employee: 12.92M
• Employees: 1,118
• Market Cap: 20.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	14.91B	1.03B	7.39%
Mar 31, 2024	13.89B	-1.54B	-10.00%
Mar 31, 2023	15.43B	224.94M	1.48%
Mar 31, 2022	15.20B	2.79B	22.47%
Mar 31, 2021	12.41B	-3.82B	-23.54%